Approval · Notice of Compliance 8814 · 2007
BARACLUDE: Notice of Compliance 8814
Issued June 6, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8814
- Date
- June 6, 2007
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph to include 96 week safety and efficacy data
- Therapeutic class
- Antiviral
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BARACLUDE | Not yet assigned | — |